Telehealth platforms like Nurx make it easier to get evaluation, support, and treatment delivered to your door
Not cardio
GLP-1-based therapy for obesity
In the meantime, Eli Lilly should remain the leader in weight loss thanks to Zepbound, and other highly promising pipeline candidates, such as retatrutide, whose recent phase 3 results have been compared to what we typically see in bariatric surgeries
Of note, albiglutide from the HARMONY trial was discontinued in 2017 due to modest sales
Key takeaways: Hashimotos and hypothyroidism do not automatically disqualify you Only medullary thyroid cancer and MEN-2 are true contraindications Weight loss may require thyroid medication adjustment Personalized endocrine care makes all the difference Whether youre located in Lafayette, San Francisco, the Bay Area, or anywhere in California via telemedicine , these decisions for my patients are always made through thoughtful, one-on-one discussions